Option Care Health (NASDAQ:OPCH) Updates FY25 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its FY25 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $1.59-1.69 for the period, compared to the consensus estimate of $1.32. The company issued revenue guidance of $5.2-5.4 billion, compared to the consensus revenue estimate of $5.24 billion. Option Care Health also updated its Q4 guidance to $0.42-0.45 EPS.

Option Care Health Stock Down 0.6 %

Shares of OPCH opened at $23.99 on Monday. The firm’s 50-day simple moving average is $23.10 and its 200 day simple moving average is $27.69. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market cap of $4.08 billion, a P/E ratio of 20.16, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.63.

Analyst Ratings Changes

OPCH has been the topic of several analyst reports. UBS Group began coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th. Barrington Research cut their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price objective for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, JMP Securities restated a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Option Care Health has a consensus rating of “Hold” and an average target price of $29.14.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.64% of the stock is owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.